By staff writers

September 7, 2018 -- Health Canada is developing a guidance to facilitate the licensing of 3D-printed medical devices, according to a report from the U.S. Food and Drug Administration (FDA).

Healthcare institutions have shown increasing interest in producing and distributing 3D-printed implants, the agency noted. The forthcoming draft guidance will center on premarket class III and class IV 3D-printed implants and provide instruction on how to make sure they meet ISO 13485 regulatory requirements.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking